From the White House website:
The Budget includes $547 million to enhance the advanced development of next generation medical countermeasures against chemical, biological, radiological and nuclear threats. In addition, the Budget includes $50 million to establish the Strategic Investor, an independent venture capital entity in the Office of the Assistant Secretary for Preparedness and Response, and continues funding for the NIH Concept Acceleration Program to assist investigators with developing promising new countermeasures, and the FDA’s Medical Countermeasures Regulatory Science Initiatives. The Department has invested $6.9 billion since 2005 to enhance America’s ability to rapidly respond to an influenza pandemic. In 2013, HHS plans to use remaining pandemic influenza resources to support the new U.S.-based advanced development and manufacturing facilities for vaccines and other biologics.